Thrombin-derived angiogenesis / wound repair · Peptide
Evidence gap: Route-specific human PK and absolute bioavailability are not established in the imported material.
Open in the interactive library →Compare with other compounds →
Human clinical research is reported in the guide, but no general tendon self-injection protocol is established.
Context: Imported field-guide summary; primary citation incomplete.
Limitations: Specific primary trial is not supplied; human development history is not proof of tendon efficacy.
Administration reported for this specific study or labeled indication.
Context: 60 participants with diabetic foot ulcers
Human study regimen: Amount: 1 or 10 µg; Route: Topical wound bed; Frequency: Twice weekly; Species: Human; Population: 60 participants with diabetic foot ulcers
Limitations: Phase I/II randomized study with standardized wound care and offloading. Healing signal reported in the per-protocol analysis.
Open this exact record in the library →Suggest a correctionThese compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.
Browse this pathway in the library →Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.